USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Biosynth AG

USPTO PatentsView assignee record - 7 granted patents across 8 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07H (SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids).

RSS updates for this company

The verdict

According to USPTO PatentsView, Biosynth ranks #34,504 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 8 technology areas.

#34,504
of 49,997 US assignees by volume
Top 39%
by Innovation Score (39.1/100)
14.3
avg claims per patent
-33%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R34504 · Foreign Corporation #34,504 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

  • GRANTS-MICRO 7 grants
  • MID-PACK #34,504/49,997
  • PHOTO-FINISH Biochemical…
  • CPC-NARROW C07H · 8 areas
  • INNOV-THIN 39.1/100
  • CLAIMS-RICH 14.3 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DOWN -33% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Biochemical Diagnostics, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Biosynth

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Biosynth's Innovation Score is 39.1/100 (top 39% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Biosynth's grants concentrate

Biosynth AG is a focused PatentsView assignee: 8 CPC subclasses with 57.1% of grants classified under C07H (SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids). Peak complete grant year is 2015 (3 grants) versus a trough of 1 in 2023. By volume, Biosynth sits between Biochemical Diagnostics, Inc. and Bittium Wireless Oy.

Biosynth's three-year grant acceleration

Biosynth AG shows 2 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Biosynth's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Biosynth holds 7 patents at rank #34,546, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Biosynth

By rank, the assignees closest to #34,546 in granted patent volume.

Leaders in C07H (Sugars)

Other assignees with the most granted patents in Biosynth's primary technology class.

Biosynth's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 39% higher than 61% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 2015202320242025 2
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Biosynth AG patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 3 42.9%
2023 1 14.3%
2024 1 14.3%
2025partial year 2 28.6%

Where it ranks

Overall rank by patents

#34,504

of 49,997 tracked assignees

Innovation Score

39.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Biosynth AG's patent record in context - here's where to go next.

  • Biosynth AG's lead technology class is C07H (SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids), 57.1% of its portfolio - see every assignee active in that class. Explore C07H
  • Ranked #34,504 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Biosynth AG against Biochemical Diagnostics, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 39.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.